[{"address1": "1375 West Fulton Street", "address2": "Suite 1300", "city": "Chicago", "state": "IL", "zip": "60607", "country": "United States", "phone": "844 445 5704", "website": "https://www.xerispharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 394, "companyOfficers": [{"maxAge": 1, "name": "Mr. John P. Shannon", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 918153, "exercisedValue": 0, "unexercisedValue": 148377}, {"maxAge": 1, "name": "Mr. Steven M. Pieper", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2023, "totalPay": 681142, "exercisedValue": 0, "unexercisedValue": 15586}, {"maxAge": 1, "name": "Ms. Beth P. Hecht J.D.", "age": 60, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 695443, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul R. Edick J.D.", "age": 68, "title": "Senior Advisor", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 1206766, "exercisedValue": 0, "unexercisedValue": 590310}, {"maxAge": 1, "name": "Dr. Kenneth E. Johnson Pharm. D., Pharm.D.", "age": 61, "title": "Senior VP of Global Development & Medical Affairs", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 596967, "exercisedValue": 0, "unexercisedValue": 31173}, {"maxAge": 1, "name": "Mr. Kevin  McCulloch", "age": 60, "title": "President & COO", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Allison  Wey", "title": "Senior Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Conner", "title": "SVP of Quality and Chief Compliance & Risk Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kendal  Korte", "title": "Senior Vice President of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anh  Nguyen M.B.A., M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1740787200, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 5.63, "open": 5.63, "dayLow": 5.51, "dayHigh": 5.7, "regularMarketPreviousClose": 5.63, "regularMarketOpen": 5.63, "regularMarketDayLow": 5.51, "regularMarketDayHigh": 5.7, "payoutRatio": 0.0, "beta": 1.208, "forwardPE": -25.363636, "volume": 2978506, "regularMarketVolume": 2978506, "averageVolume": 2512295, "averageVolume10days": 4229590, "averageDailyVolume10Day": 4229590, "bid": 4.06, "ask": 7.05, "bidSize": 1, "askSize": 1, "marketCap": 858985216, "fiftyTwoWeekLow": 1.69, "fiftyTwoWeekHigh": 6.07, "priceToSalesTrailing12Months": 4.2299957, "fiftyDayAverage": 4.1254, "twoHundredDayAverage": 3.1766, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1058811968, "profitMargins": -0.27003, "floatShares": 146657227, "sharesOutstanding": 153940000, "sharesShort": 11209763, "sharesShortPriorMonth": 10265230, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0728, "heldPercentInsiders": 0.03971, "heldPercentInstitutions": 0.42868, "shortRatio": 3.4, "shortPercentOfFloat": 0.0746, "impliedSharesOutstanding": 156128000, "bookValue": -0.198, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -54836000, "trailingEps": -0.37, "forwardEps": -0.22, "enterpriseToRevenue": 5.214, "enterpriseToEbitda": -68.416, "52WeekChange": 1.6074767, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 5.58, "targetHighPrice": 8.0, "targetLowPrice": 4.0, "targetMeanPrice": 6.25, "targetMedianPrice": 6.25, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 71621000, "totalCashPerShare": 0.465, "ebitda": -15476000, "totalDebt": 271447008, "quickRatio": 1.115, "currentRatio": 1.669, "totalRevenue": 203070000, "revenuePerShare": 1.384, "returnOnAssets": -0.05333, "grossProfits": 166238000, "freeCashflow": -27807376, "operatingCashflow": -36981000, "revenueGrowth": 0.354, "grossMargins": 0.81861997, "ebitdaMargins": -0.07621, "operatingMargins": 0.12944001, "financialCurrency": "USD", "symbol": "XERS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Xeris Biopharma Holdings, Inc.", "regularMarketChangePercent": -0.8881029, "regularMarketPrice": 5.58, "regularMarketDayRange": "5.51 - 5.7", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 2512295, "fiftyTwoWeekLowChange": 3.8899999, "fiftyTwoWeekLowChangePercent": 2.301775, "fiftyTwoWeekRange": "1.69 - 6.07", "fiftyTwoWeekHighChange": -0.49000025, "fiftyTwoWeekHighChangePercent": -0.08072492, "fiftyTwoWeekChangePercent": 160.74767, "earningsTimestamp": 1741262400, "earningsTimestampStart": 1746702000, "earningsTimestampEnd": 1747047600, "earningsCallTimestampStart": 1741267800, "earningsCallTimestampEnd": 1741267800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.37, "epsForward": -0.22, "epsCurrentYear": -0.1, "priceEpsCurrentYear": -55.8, "fiftyDayAverageChange": 1.4545999, "fiftyDayAverageChangePercent": 0.35259607, "twoHundredDayAverageChange": 2.4034, "twoHundredDayAverageChangePercent": 0.7565951, "priceToBook": -28.181818, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Xeris Pharmaceuticals, Inc.", "nameChangeDate": "2025-03-28", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "postMarketChangePercent": 0.0, "postMarketPrice": 5.58, "postMarketChange": 0.0, "regularMarketChange": -0.05000019, "corporateActions": [], "postMarketTime": 1743192307, "regularMarketTime": 1743192001, "exchange": "NMS", "messageBoardId": "finmb_105901792", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Xeris Biopharma Holdings, Inc.", "marketState": "CLOSED", "displayName": "Xeris Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]